Table 3.
Variable | Ipsilateral catheter | Contralateral catheter | P value |
---|---|---|---|
No. of patients | 27 | 62 | |
Age (y) | 52 ± 11 | 55 ± 15 | 0.4 |
Male sex | 11 (41%) | 24 (39%) | 0.9 |
Black race | 23 (85%) | 49 (79%) | 0.5 |
Diabetes | 17 (63%) | 32 (52%) | 0.3 |
Hypertension | 23 (85%) | 57 (90%) | 0.5 |
CAD | 6 (22%) | 12 (19%) | 0.7 |
PVD | 4 (15%) | 9 (14%) | 0.9 |
CVD | 6 (22%) | 10 (16%) | 0.5 |
CHF | 4 (15%) | 16 (26%) | 0.3 |
AVG location | 0.8 | ||
Forearm | 8 (30%) | 20 (32%) | |
Upper arm | 19 (70%) | 42 (68%) | |
AVG side | <0.001 | ||
Left | 10 (37%) | 61 (98%) | |
Right | 17 (63%) | 1 (2%) | |
Catheter side | <0.001 | ||
Left | 10 (37%) | 1 (2%) | |
Right | 17 (63%) | 61 (98%) |
Values for continuous variables given as mean +/− SD; values for categorical variables given as number (percentage). AVF had to have been placed after initiation of hemodialysis.
CAD, coronary artery disease; PVD, peripheral vascular disease; CVD, cerebrovascular disease, CHF, congestive heart failure; AVG, arteriovenous graft.